X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (41224) 41224
Newsletter (7429) 7429
Newspaper Article (2890) 2890
Book Chapter (214) 214
Transcript (164) 164
Magazine Article (128) 128
Reference (52) 52
Book / eBook (47) 47
Dissertation (41) 41
Publication (23) 23
Web Resource (11) 11
Streaming Video (7) 7
Conference Proceeding (6) 6
Journal / eJournal (4) 4
Trade Publication Article (3) 3
Book Review (2) 2
Government Document (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26727) 26727
non-hodgkin's lymphomas (22153) 22153
male (14808) 14808
non-hodgkins-lymphoma (14333) 14333
female (14329) 14329
oncology (13297) 13297
middle aged (12217) 12217
cancer (11901) 11901
adult (10769) 10769
aged (10066) 10066
hematology (9502) 9502
research (8414) 8414
lymphomas (7810) 7810
chemotherapy (7499) 7499
t cells (7406) 7406
care and treatment (6584) 6584
prognosis (5479) 5479
non-hodgkin's lymphoma (5465) 5465
lymphoma (5394) 5394
antineoplastic combined chemotherapy protocols - therapeutic use (4165) 4165
aged, 80 and over (4130) 4130
adolescent (4052) 4052
treatment outcome (3900) 3900
non-hodgkin lymphoma (3835) 3835
rituximab (3734) 3734
leukemia (3534) 3534
health aspects (3533) 3533
risk factors (3462) 3462
b-cell lymphoma (3377) 3377
analysis (3267) 3267
pathology (3254) 3254
non-hodgkin-lymphoma (3232) 3232
diagnosis (3189) 3189
retrospective studies (3107) 3107
medical research (2935) 2935
transplantation (2881) 2881
therapy (2789) 2789
animals (2736) 2736
disease (2680) 2680
medicine, experimental (2505) 2505
lymphoma, non-hodgkin - pathology (2495) 2495
child (2490) 2490
tumors (2464) 2464
drug therapy (2462) 2462
survival (2429) 2429
immunohistochemistry (2396) 2396
hemic and lymphatic diseases (2388) 2388
genetic aspects (2295) 2295
expression (2281) 2281
lymphoma, non-hodgkin - drug therapy (2232) 2232
immunology (2211) 2211
medicine & public health (2140) 2140
follicular lymphoma (2054) 2054
neoplasm staging (2014) 2014
physical fitness (1985) 1985
young adult (1982) 1982
antineoplastic agents - therapeutic use (1928) 1928
chronic lymphocytic-leukemia (1914) 1914
antineoplastic agents (1899) 1899
classification (1865) 1865
disease-free survival (1864) 1864
malignant-lymphoma (1852) 1852
survival rate (1834) 1834
survival analysis (1815) 1815
non-hodgkins-lymphomas (1812) 1812
risk (1805) 1805
antimitotic agents (1802) 1802
universities and colleges (1802) 1802
combined modality therapy (1795) 1795
oncology, experimental (1769) 1769
immunotherapy (1737) 1737
apoptosis (1709) 1709
cyclophosphamide - administration & dosage (1675) 1675
follow-up studies (1661) 1661
radiotherapy (1656) 1656
lymphoma, large b-cell, diffuse - pathology (1646) 1646
epidemiology (1641) 1641
clinical trials (1638) 1638
medicine, general & internal (1626) 1626
stem cells (1585) 1585
patients (1573) 1573
radiology, nuclear medicine & medical imaging (1552) 1552
lymphoma, non-hodgkin - therapy (1482) 1482
child, preschool (1439) 1439
development and progression (1429) 1429
surgery (1427) 1427
vincristine - administration & dosage (1427) 1427
biopsy (1420) 1420
lymphoma, b-cell - pathology (1411) 1411
pharmaceutical industry (1403) 1403
immune system diseases (1391) 1391
non-hodgkins lymphoma (1371) 1371
lymphoma, large b-cell, diffuse - drug therapy (1370) 1370
diagnosis, differential (1365) 1365
doxorubicin - administration & dosage (1365) 1365
antineoplastic combined chemotherapy protocols - administration & dosage (1332) 1332
cyclophosphamide (1317) 1317
mice (1295) 1295
incidence (1247) 1247
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (20) 20
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - General (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (49901) 49901
Japanese (672) 672
French (470) 470
German (466) 466
Chinese (321) 321
Spanish (221) 221
Russian (132) 132
Polish (72) 72
Czech (29) 29
Portuguese (25) 25
Hungarian (16) 16
Korean (16) 16
Italian (14) 14
Turkish (9) 9
Persian (8) 8
Slovak (3) 3
Slovenian (3) 3
Croatian (2) 2
Dutch (2) 2
Arabic (1) 1
Greek (1) 1
Manx (1) 1
Serbian (1) 1
Thai (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 02/2007, Volume 136, Issue 3, pp. 439 - 447
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2009, Volume 145, Issue 3, pp. 344 - 349
Journal Article
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 06/2019, Volume 104, Issue 6, pp. 1202 - 1208
We evaluated early disease progression and its impact on overall survival (OS) in previously untreated follicular lymphoma patients in GALLIUM ( ), and... 
Journal Article
Nature medicine, ISSN 1546-170X, 2018, Volume 24, Issue 5, pp. 679 - 690
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 7, p. e41658
Background: Recent research has shown a correlation between immune microenvironment and lymphoma biology. This study aims to investigate the prognostic... 
SURVIVAL | LYMPHOPENIA | ABSOLUTE MONOCYTE | PROGNOSTIC-FACTOR | RESPONSE CRITERIA | MULTIDISCIPLINARY SCIENCES | TUMOR | NON-HODGKIN-LYMPHOMA | COUNT | EXPRESSION | CHEMOTHERAPY | Doxorubicin - therapeutic use | Multivariate Analysis | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prognosis | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Treatment Outcome | Cyclophosphamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - diagnosis | Lymphoma, Large B-Cell, Diffuse - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Monocytes - pathology | Vincristine - therapeutic use | Female | ROC Curve | Aged | Leukocyte Count | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Care and treatment | Anthracyclines | Cyclophosphamide | Corticosteroids | Lymphocytes | Prednisone | Non-Hodgkin's lymphomas | Therapy | Working groups | Laboratories | Cytotoxicity | Oncology | Multivariate analysis | Cancer therapies | Doxorubicin | Training | Bioindicators | Neutropenia | Risk groups | Cut-off | Melanoma | Rituximab | Data processing | Risk analysis | Gene expression | Survival | Patients | Vincristine | Lymphoma | Survival analysis | Chemotherapy | Monocytes | Lymphocytes B | Medical prognosis | Biomarkers | Lymphomas | Apoptosis | B-cell lymphoma
Journal Article
Journal Article